半年度强势板块之创新药，北证标的一览——

Group 1 - The article reviews the performance of the innovative drug sector in the first half of the year, noting that both the North Exchange and Shanghai-Shenzhen markets have seen significant interest and investment in this theme [1] - Currently, the innovative drug sector is in a phase of consolidation after an initial surge, coinciding with July, a period that emphasizes the importance of corporate fundamentals [1] - A summary of innovative drug concept stocks listed on the North Exchange is provided, highlighting their performance and market interest [1]